Germany· DE-A57-1c70ea7dcebd482b
Effortil Tropfen
A etilefrine product containing etilefrine hydrochloride, registered in Germany by Serb Sa. The same ATC class is registered in 8 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Etilefrine is registered in 8 of 19 countries.
Countries holding a registration under ATC C01CA01 (etilefrine), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 5 of them publish a price we can compare per daily dose
Etilefrine · ATC C01CA01
8 / 19 countries
- Belgiumprice
- Finlandprice
- Germany
- Japan
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of etilefrine costs, country by country.
Normalised to the WHO defined daily dose (50 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Etilefrine · price per daily dose (50 mg)
USD · FX 28 Sept 2026
- CH Switzerland$2.39
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Etilefrine Hydrochloride
- Manufacturer
- Serb Sa
- Country
- Germany (DE)
- ATC code
- C01CA01
- ATC class
- Etilefrine
- Defined daily dose
- 50 mg, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Etilefrine in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandEffortilLaboratorium Galenowe Olsztyn Sp. z o.o.
- FinlandEffortilSERB SA
- BelgiumEffortil 5 mgSERB
- FranceEFFORTIL 5 mg, compriméSERB
- United KingdomEffortil 5mg tabletsImported (Japan)
- SwitzerlandEffortil
- SwedenEffortil 5 mg TablettSERB S.A.
- NorwayEffortilBoehringer Ingelheim
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Austria · Effortil
- Belgium · Effortil
- Finland · Effortil
- France · Effortil, Etilefrine S.E.R.B.
- Italy · Effortil
- Luxembourg · Effortil
- Poland · Effortil
- Sweden · Effortil
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/914879ff-9357-4f45-8317-3aa55a96ef8c GET /v1/drugs/914879ff-9357-4f45-8317-3aa55a96ef8c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Etilefrine Hydrochloride",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about etilefrine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.